Clinical Trials Logo

Filter by:
NCT ID: NCT04987801 Recruiting - Drug Toxicity Clinical Trials

Evaluation of Drug Overdose Poisoning Cases and Indications for ICU Admission

Start date: April 1, 2021
Phase:
Study type: Observational

1. Evaluation of drug overdose cases presented to Assiut university hospitals' adults and pediatric emergency departments (EDs) in one year period. 2. Evaluation the role of intensive care unit (ICU) admission in these cases and possible scoring system for common groups of drug overdose.

NCT ID: NCT04994418 Recruiting - Inflammation Clinical Trials

The Impact of Sodium and Fructose on Blood Pressure and Inflammation

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The goal of this study is to determine the impact of dietary sodium and fructose on blood pressure and inflammation in young healthy adults.

NCT ID: NCT05003427 Recruiting - Oral Carcinoma Clinical Trials

68Ga-FAPI-04 PET/CT for the Detection of Oral Carcinoma

Start date: April 1, 2021
Phase: Early Phase 1
Study type: Interventional

FAPI is a fibroblast activation protein inhibitor and 68Ga-FAPI-04 is a potential new imaging agent for imaging of carcinoma. 68Ga-FAPI-04 PET/CT is helpful to clarify the benign, malignant and invasive range of the oral carcinoma, locate and qualitatively diagnose the tumor, and make early diagnosis and restaging of recurrent tumor.

NCT ID: NCT05022186 Recruiting - Clinical trials for Mild Cognitive Impairment

The Effects of Cannabidiol and Homotaurine in Patients With Mild Cognitive Impairment

Start date: April 1, 2021
Phase: Phase 4
Study type: Interventional

A Randomized Clinical Trial that will compare the effects of Cannabidiol and Homotaurine in cognition and mental health in patients with Mild Cognitive Impairment and APOE ε4 carriers. Ninety patients will be recruited and they will be randomly distributed in three groups. The first group will receive treatment with Cannabidiol 5%, the second group will receive treatment with Vivimind and the third group will not receive any treatment. The three groups will be compared by using an extensive neuropsychological examination and biomarkers' results from cerebrospinal fluid and blood

NCT ID: NCT05024526 Recruiting - Clinical trials for Acute Ischemic Stroke

Protective Effects of Edaravone Dexborneol

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The patients of acute ischemic stroke were divided into two groups, edaravone dexborneol treatment group and edaravone treatment group. The purpose of this study was to observe the changes of imaging and the improvement of NIHSS and mRS in different groups.

NCT ID: NCT05027412 Recruiting - Bladder Cancer Clinical Trials

En Bloc TURBT With Collins Loop vs Conventional TURBT

TURBT
Start date: April 1, 2021
Phase: N/A
Study type: Interventional

This is a prospective, randomized, randomized and single-blind study in patients diagnosed with primary bladder CV. Patients diagnosed by cystoscopy of a bladder tumor and with indication for endoscopic surgical treatment, who meet the inclusion criteria, and who sign the Informed Consent (IC), will be randomized.

NCT ID: NCT05029401 Recruiting - Clinical trials for Opiate Withdrawal Syndrome

A Study of Oral Ibogaine in Opioid Withdrawal

Start date: April 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Study DMX-IB 201 is a Phase 1/2a study of ibogaine consisting of an initial single ascending dose escalation stage to determine the maximum tolerated dose (MTD) or treat-to-target dose (TTD) in healthy volunteers, followed by a randomized, double-blind, placebo-controlled proof of concept stage to demonstrate the efficacy, safety and tolerability of the selected dose in opioid-dependent patients who seek medically supervised opioid withdrawal

NCT ID: NCT05031403 Recruiting - Stroke Clinical Trials

Development and Application of Tele-Neuro Rehabilitation System

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

Disability due to neurological diseases is increasing in our country and world. With regular physiotherapy and rehabilitation, as well as patients' symptoms are brought under control, their affected functions in daily life are achieved and levels of independence and physical activity increase. Thus, the patients' quality of life and participation in social life is improved and patients are supported in physical, social and psychological terms. In recent years, it has been reported that exercise with telerehabilitation systems increase the compliance and participation of patients to the treatment, and even this system seems as effective as standard rehabilitation practices. Delivering the treatment through telerehabilitation system when that patients cannot receive it in the hospital due to epidemic, restriction, transfer difficulties, personal and environmental limitations will enable patients to receive the rehabilitation services.Telerehabilitation system is frequently encountered in the abroad, but there are limited systems with Turkish version specific to this patient group in our country. The aim of project is to develop and detect the efficiency of a telerehabilitation system which is used to assess, follow and design home-based rehabilitation program among individuals with chronic neurological diseases who have difficulty in participating in physiotherapy and rehabilitation services because of personal or environmental reasons.

NCT ID: NCT05036616 Recruiting - AKI Clinical Trials

Separation Versus Integrated Approach in Combining ECMO With CRRT

Start date: April 1, 2021
Phase:
Study type: Observational

This investigation aims to evaluate the filter life time of CRRT membrane and complication of combining ECMO and CRRT.

NCT ID: NCT05038995 Recruiting - Cow Milk Allergy Clinical Trials

The Effect of Early Cow's Milk Elimination Diet on the Growth Pattern

Start date: April 1, 2021
Phase:
Study type: Observational

This study aimed to survey the growth of children who were on elimination diet due to cow milk allergy in Turkey. 0-5 year aged children diagnosed with cow's milk allergy (CMA) and healthy age-sex-matched children as the control group was planned for inclusion. Participants will be included in the study by consecutive sampling. The anthropometry measurements (height-for-age [HFA], weight-for-age [WFA], and weight-for-height [WtHt]) will be evaluated according to the Z-score using the WHO ANTHRO [Z-score = Patient's value - Average value / Standard Deviation (SD)]. The Z-score (SDS) in the average child by age was "0".